Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 20, 2026 08:00 ET | Source: Gelteq Limited

Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway

MELBOURNE, Australia, May 20, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) today announced the commencement of its first clinical trial for an antiparasitic drug candidate powered by Gelteq®...
May 12, 2026 08:00 ET | Source: Gelteq Limited

Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth

MELBOURNE, Australia, May 12, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) today announced that it has secured strategic debt financing of up to USD $3.5 million to accelerate its...
January 13, 2026 09:00 ET | Source: Gelteq Limited

Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform

MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of advanced gel-based oral delivery systems, today...
June 10, 2025 07:30 ET | Source: Gelteq Limited

Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white label...
August 06, 2024 09:00 ET | Source: Gelteq Pty Ltd

Gelteq Strengthens Partnership with Monash Innovation Labs

MELBOURNE, Australia, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing...